Cite
HARVARD Citation
Lu, S. et al. (2022). Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non–Small Cell Lung Cancer. Cancer journal. 28 (2), pp. 96-104. [Online].